These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15230891)

  • 1. Pentazocine-induced cutaneous sclerosis and panniculitis in an Indian male.
    Gandhi V; Agrawal SK; Chatterjee AK; Sachdeva B; Bhattacharya SN
    Int J Dermatol; 2004 Jul; 43(7):516-7. PubMed ID: 15230891
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous complications of parenteral pentazocine.
    Winfield JB; Greer K
    South Med J; 1974 Mar; 67(3):292-4. PubMed ID: 4814178
    [No Abstract]   [Full Text] [Related]  

  • 3. Pentazocine induced ulceration of the buttocks.
    Kathuria S; Ramesh V; Singh A
    Indian J Dermatol Venereol Leprol; 2012; 78(4):521. PubMed ID: 22772644
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Pentazocine problems.
    Beckner TF
    JAMA; 1974 Mar; 227(12):1383. PubMed ID: 4406020
    [No Abstract]   [Full Text] [Related]  

  • 5. Pentazocine-induced fibromyositis and contracture.
    Das CP; Thussu A; Prabhakar S; Banerjee AK
    Postgrad Med J; 1999 Jun; 75(884):361-2. PubMed ID: 10435175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentazocine-induced cutaneous scarring.
    Fleming JD; Hopper A; Robson A; Singh M; Barker J
    Clin Exp Dermatol; 2014 Jan; 39(1):115-6. PubMed ID: 23773073
    [No Abstract]   [Full Text] [Related]  

  • 7. Atypical ulcerations.
    Mak RK; Reynaert SM; O'Donoghue NB; Black MM
    Clin Exp Dermatol; 2006 Mar; 31(2):311-2. PubMed ID: 16487134
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous complications of parenterally administered pentazocine.
    Winfield JB; Greer K
    JAMA; 1973 Oct; 226(2):189-90. PubMed ID: 4740912
    [No Abstract]   [Full Text] [Related]  

  • 9. Parenteral pentazocine and diabetes mellitus: a double whammy for cutaneous complication.
    Phaujdar S; Sarkar RN; Bhattacharyya K
    J Assoc Physicians India; 2014 Oct; 62(10):52-4. PubMed ID: 25906524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local changes at the site of pentazocine injection.
    Schlicher JE; Zuehlke RL; Lynch PJ
    Arch Dermatol; 1971 Jul; 104(1):90-1. PubMed ID: 5120170
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pentazocine (Fortralin). Skin complications following injection].
    Naess K
    Tidsskr Nor Laegeforen; 1974 May; 94(15):1009. PubMed ID: 4840764
    [No Abstract]   [Full Text] [Related]  

  • 12. Pentazocine induced myocutaneous sclerosis.
    Hertzman A; Toone E; Resnik CS
    J Rheumatol; 1986 Feb; 13(1):210-4. PubMed ID: 3701735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited cutaneous scleroderma induced by pentazocine abuse.
    Wanchu A; Misra R
    J Assoc Physicians India; 1995 Feb; 43(2):145. PubMed ID: 9282692
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous complications of pentazocine injections.
    Parks DL; Perry HO; Muller SA
    Arch Dermatol; 1971 Sep; 104(3):231-5. PubMed ID: 4255441
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Parenteral pentazocine problems.
    Rush SJ
    JAMA; 1974 Jan; 227(1):79. PubMed ID: 4859644
    [No Abstract]   [Full Text] [Related]  

  • 16. Concern about use of narcotics for pain in sickle cell anemia.
    Johnson NA
    Am Fam Physician; 1995 Jan; 51(1):47-8. PubMed ID: 7810478
    [No Abstract]   [Full Text] [Related]  

  • 17. Pentazocine-induced contractures: Dilemma in management.
    Kumar D; Gupta A; Sharma VP; Yadav G; Singh A; Verma AK
    Indian J Pharmacol; 2015; 47(4):451-3. PubMed ID: 26288482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of cancer pain.
    N Engl J Med; 1986 Aug; 315(6):394-6. PubMed ID: 3736613
    [No Abstract]   [Full Text] [Related]  

  • 19. Opioids for intractable pain: the good, the bad and the ugly.
    Gallagher RM
    Pain Med; 2005; 6(2):103-4. PubMed ID: 15773872
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cutaneous necrosis with sclerodermiform development after a subcutaneous injection of calcium heparinate].
    Barthélémy H; Hermier C; Perrot H
    Ann Dermatol Venereol; 1985; 112(3):245-7. PubMed ID: 4062171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.